This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DAKAR, Senegal (AP) — Senegal and Rwanda ...

Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next milestone in the execution of its ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific ...